Determine immunity in Germany

The study (survey 2022)


We invite you to make an important contribution to the understanding of SARS-CoV-2 and other infectious diseases with us a second or third time.

After 1 or 2 years we would like to ask you again for information about your health situation in the form of a questionnaire. This questionnaire will be sent to you by post or email. With 3,000 MuSPAD participants from three districts, we would like to ask for a blood sample again. In some cases we will also ask you to take two drops of capillary blood yourself, which you will take from your fingertip (finger prick method). The blood drops are placed in a device that tests the capillary blood for antibodies. The result of whether SARS-CoV-2 antibodies are present in a sample is visible within a few minutes.

The aim of the renewed survey is to better understand the immunity situation against SARS-CoV-2 and other infectious diseases in the population. This helps to better estimate the spread of these infectious diseases in the population. It is about SARS-CoV-2 as well as infectious diseases such as the flu. This data can then also be used to better understand how measures taken during the pandemic have impacted the spread of various infectious diseases. These surveys thus help to better assess and more specifically design the effects of measures against infectious diseases in the future.
The nationwide antibody study is funded by the Helmholtz Association of German Research Centers.

In addition to the Helmholtz Center for Infection Research, the Natural Science and Medical Institute in Reutlingen, the University of Münster, the University of Oldenburg and the Biobank of the Hannover Medical School are also participating in this study.

I Participant information MuSPAD (Version 1.6)

MuSPAD Logo blue